Takeover price - I believe anyone will have to pay the full price to takeover VLA. The big shareholders are all USA funds. They backed the company in the last two $28m fund raisings. They are not in it for measly 30% gains. They understand the true value of successful clinical trials. They are in it for many multiples of their investment price. They have deep pockets and I expect would reject any bid that does not have a $0.5b cash upfront plus clinical success milestones
- Forums
- ASX - By Stock
- VLA
- Roth Report
Roth Report, page-59
Featured News
Add VLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online